Data obtained by large observational studies and meta-analysis indicate the absence of an increased risk of lymphoma related to therapy with anti-TNF-α, but there is limited information in literature about the safety of sequential, multiple biological agents therapy for a time longer than three years. We hereby present a case of psoriatic arthritis developing non-Hodgkin lymphoma after a six-year history of poorly effective therapy with different anti-TNF-α
Psoriasis is a polygenic, systemic inflammatory disease seen in 2% to 3% of the population and leads...
Background: Adalimumab, golimumab, infliximab, certolizumab, and etanercept are five anti-tumor necr...
Abstract Rheumatoid arthritis, RA, is a chronic autoimmune disease characterized by joint pain, tend...
Data obtained by large observational studies and meta-analysis indicate the absence of an increased ...
Context: The efficacy and favorable safety profile of anti-tumor necrosis factor (TNF) agents in the...
Background: Inteleukin (IL)12 and IL23 are two main cytokines involved in the pathogenesis of immune...
Malignancies have been reported in patients with rheumatoid arthritis, psoriatic arthritis and ankyl...
BACKGROUND: Lymphocyte expansion and true lymphocytosis are commonly observed in the everyday clini...
Context: The efficacy and favorable safety profile of anti-tumor necrosis factor (TNF) agents in the...
Tumor necrosis factor alpha inhibitors revolutionized the management of patients affected by autoimm...
Introduction: The tumor necrosis factor ($TNF-\alpha$) was initially described as lymphotoxin or cac...
Abstract Context: The efficacy and favorable safety profile of anti-tumor necrosis factor (TNF) age...
Objective: Psoriatic arthritis (PsA) is an inflammatory arthropathy, associated with skin and/or nai...
Background: Early diagnosis is the key to successful treatment of inflammatory rheumatic diseases an...
Introduction: Psoriatic arthritis is a common and often severe chronic joint disorder associated wit...
Psoriasis is a polygenic, systemic inflammatory disease seen in 2% to 3% of the population and leads...
Background: Adalimumab, golimumab, infliximab, certolizumab, and etanercept are five anti-tumor necr...
Abstract Rheumatoid arthritis, RA, is a chronic autoimmune disease characterized by joint pain, tend...
Data obtained by large observational studies and meta-analysis indicate the absence of an increased ...
Context: The efficacy and favorable safety profile of anti-tumor necrosis factor (TNF) agents in the...
Background: Inteleukin (IL)12 and IL23 are two main cytokines involved in the pathogenesis of immune...
Malignancies have been reported in patients with rheumatoid arthritis, psoriatic arthritis and ankyl...
BACKGROUND: Lymphocyte expansion and true lymphocytosis are commonly observed in the everyday clini...
Context: The efficacy and favorable safety profile of anti-tumor necrosis factor (TNF) agents in the...
Tumor necrosis factor alpha inhibitors revolutionized the management of patients affected by autoimm...
Introduction: The tumor necrosis factor ($TNF-\alpha$) was initially described as lymphotoxin or cac...
Abstract Context: The efficacy and favorable safety profile of anti-tumor necrosis factor (TNF) age...
Objective: Psoriatic arthritis (PsA) is an inflammatory arthropathy, associated with skin and/or nai...
Background: Early diagnosis is the key to successful treatment of inflammatory rheumatic diseases an...
Introduction: Psoriatic arthritis is a common and often severe chronic joint disorder associated wit...
Psoriasis is a polygenic, systemic inflammatory disease seen in 2% to 3% of the population and leads...
Background: Adalimumab, golimumab, infliximab, certolizumab, and etanercept are five anti-tumor necr...
Abstract Rheumatoid arthritis, RA, is a chronic autoimmune disease characterized by joint pain, tend...